Purple Biotech Ltd. (PPBT)
1.64
-0.01
(-0.61%)
USD |
NASDAQ |
Aug 26, 13:02
Purple Biotech Net Income (Quarterly) : 0.4486M for June 30, 2026
Net Income (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.4486M |
| March 31, 2026 | -0.0888M |
| December 31, 2025 | -23.79M |
| September 30, 2025 | -1.311M |
| June 30, 2025 | -1.112M |
| March 31, 2025 | -0.4536M |
| December 31, 2024 | -0.4183M |
| September 30, 2024 | -0.668M |
| June 30, 2024 | -2.415M |
| March 31, 2024 | -3.781M |
| December 31, 2023 | -4.859M |
| September 30, 2023 | -5.055M |
| June 30, 2023 | -5.16M |
| March 31, 2023 | -4.903M |
| Date | Value |
|---|---|
| December 31, 2022 | -6.043M |
| September 30, 2022 | -4.849M |
| June 30, 2022 | -3.552M |
| March 31, 2022 | -7.316M |
| December 31, 2015 | -1.266M |
| September 30, 2015 | -1.264M |
| June 30, 2015 | -0.8709M |
| March 31, 2015 | -0.686M |
| December 31, 2014 | -0.9233M |
| September 30, 2014 | -1.282M |
| June 30, 2014 | -1.798M |
| March 31, 2014 | -1.466M |
| December 31, 2013 | -0.3256M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Teva Pharmaceutical Industries Ltd. | -585.89M |
| RedHill Biopharma Ltd. | -- |
| MediWound Ltd. | -7.392M |
| Sol-Gel Technologies Ltd. | -3.681M |
| PolyPid Ltd. | -7.849M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | -0.4486M |
| EPS Diluted (Quarterly) | 0.4069 |
| Enterprise Value | -3.359M |
| Earnings Yield | -1.71K% |
| Normalized Earnings Yield | -856.74 |